AKBA R&D Expense Growth
Akebia Therapeutics Inc · R&D Expense Growth
AKBA R&D Expense Growth
Latest reported65.62%period ending
AKBA FY R&D Growth (YoY) (0.00% → 65.62%)
Latest values, visible window
High-resolution chart · PNG
AKBA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 65.6194% | |
| -40.3098% | |
| -61.9974% | |
| 12.265% | |
| -32.3285% | |
| -32.3511% | |
| 10.96% | |
| 26.0619% | |
| 99.4153% | |
| 169.1673% | |
| 69.3677% | |
| 135.568% | |
| 91.4347% | |
| 0% |